Chronic renal failure causes: Difference between revisions
Rabin Bista (talk | contribs) |
No edit summary |
||
Line 8: | Line 8: | ||
==Causes of Chronic Kidney Disease== | ==Causes of Chronic Kidney Disease== | ||
According to the National Kidney Foundation the 2 most important causes of CKD are diabetes and hypertension accounting for more than one third of all cases often indicating early detection strategies. Beyond diabetes and hypertension other causes like glomerulonephritis, inherited disorders, chronic infections, and urinary tract obstruction account for most of the remaining cases.<ref name="pmid12859163">{{cite journal| author=Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al.| title=National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. | journal=Ann Intern Med | year= 2003 | volume= 139 | issue= 2 | pages= 137-47 | pmid=12859163 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12859163 }} </ref> Following the 2013 US Renal Data System report, a detailed calculation of the most common etiologies of ESRD in the United States adjusted for age, race and gender is shown below:<ref>U.S. Renal Data System, [http://www.usrds.org/adr.aspx|USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States], National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2013.</ref> | According to the National Kidney Foundation the 2 most important causes of CKD are diabetes and hypertension accounting for more than one third of all cases often indicating early detection strategies. Beyond diabetes and hypertension other causes like glomerulonephritis, inherited disorders, chronic infections, and urinary tract obstruction account for most of the remaining cases.<ref name="pmid12859163">{{cite journal| author=Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al.| title=National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. | journal=Ann Intern Med | year= 2003 | volume= 139 | issue= 2 | pages= 137-47 | pmid=12859163 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12859163 }} </ref> Following the 2013 US Renal Data System report, a detailed calculation of the most common etiologies of ESRD in the United States adjusted for age, race and gender is shown below:<ref>U.S. Renal Data System, [http://www.usrds.org/adr.aspx|USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States], National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2013.</ref> | ||
[[Image:CKD_stats.png|600px|center]] | [[Image:CKD_stats.png|600px|center]] | ||
===Common Causes=== | |||
*[[Alport's syndrome]] | *[[Alport's syndrome]] | ||
*[[Amyloidosis]] | *[[Amyloidosis]] | ||
Line 68: | Line 64: | ||
*[[Vesicoureteral reflux]] | *[[Vesicoureteral reflux]] | ||
*[[Wegener's granulomatosis]] | *[[Wegener's granulomatosis]] | ||
===Causes by Organ System=== | |||
{|style="width:80%; height:100px" border="1" | |||
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | |||
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Amyloidosis]], [[Essential hypertension]], [[Hypertension]], [[Hypertensive nephrosclerosis]], [[Hypotension]], [[Intraglomerular hypertension]], [[Malignant hypertension]], [[Renal artery stenosis]], [[Renal vein thrombosis]], [[Scleroderma]], [[Systemic hypertension]], [[Thrombotic thrombocytopenic purpura]], [[Vasculitis]], [[Wegener's granulomatosis]] | |||
|- | |||
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning''' | |||
|bgcolor="Beige"| [[Bismuth]], [[Carbon tetrachloride]], [[Lead]], [[Lithium]], [[Pamidronate]], [[Radiocontrast agents]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Dental''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Dermatologic''' | |||
|bgcolor="Beige"| [[Scleroderma]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Drug Side Effect''' | |||
|bgcolor="Beige"| [[Ace inhibitors]], [[Acetominophen]], [[Acyclovir]], [[Allopurinol]], [[Aminoglycosides]], [[Amphotericin b]], [[Angiotensin-converting enzyme inhibitors]], [[Anticoagulants]], [[Aspirin]], [[Bevacizumab]], [[Carboplatin]], [[Carmustine]], [[Cefoxitin ]], [[Chloroquine]], [[Cimetidine]], [[Cisplatin]], [[Cyclosporine]], [[Diflunisal]], [[Erythromycin]], [[Febuxostat]], [[Ferumoxytol]], [[Flucytosine]], [[Foscarnet]], [[Furosemide]], [[Gadopentetate]], [[Gentamicin]], [[Hydroxychloroquine]], [[Ifosfamide]], [[Infliximab]], [[Isoniazid]], [[Laxatives]], [[Lithium]], [[Lomustine]], [[Mesalamine]], [[Methicillin]], [[Mitomycin c]], [[Nitrosourea]], [[Nsaids]], [[Penicillin]], [[Pentamidine]], [[Phenytoin]], [[Propylthiouracil]], [[Protease inhibitors]], [[Quinine]], [[Rifampicin]], [[Saxagliptin]], [[Sulfa-containing antibiotics]], [[Sulfonamides]], [[Sulindac]], [[Tacrolimus]], [[Thiazides]], [[Tizanidine]], [[Trimethoprim ]], [[Vancomycin]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Ear Nose Throat''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Endocrine''' | |||
|bgcolor="Beige"| [[Amyloidosis]], [[Hyperoxaluria, primary type 1]], [[Hyperoxaluria, primary type 2]], [[Hyperoxaluria, primary type 3]], [[Hyperoxaluria]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Environmental''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Gastroenterologic''' | |||
|bgcolor="Beige"| [[Glycogenosis type 1b]], [[Tubulointerstitial disease]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Genetic''' | |||
|bgcolor="Beige"| [[Acute intermittent porphyria ]], [[Adenine phosphoribosyltransferase deficiency]], [[Alport's syndrome]], [[Alström syndrome]], [[Barakat syndrome]], [[Bardet-biedl syndrome]], [[Dent disease]], [[Denys-drash syndrome]], [[Fabry's disease]], [[Finnish congenital nephrotic syndrome]], [[Frasier syndrome]], [[Galloway-mowat syndrome]], [[Hereditary nephritides]], [[Hereditary onycho-osteodysplasia]], [[Interferons]], [[Jeune thoracic dystrophy syndrome]], [[Lesch-nyhan syndrome]], [[Loken senior syndrome]], [[Lowe syndrome]], [[Mainzer-saldino disease]], [[Papillorenal syndrome]], [[Recurrent hereditary polyserositis]], [[Sensenbrenner syndrome]], [[Townes-brocks syndrome]], [[X-linked hypophosphataemia]], [[X-linked recessive nephrolithiasis type 1]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Hematologic''' | |||
|bgcolor="Beige"| [[Hemolytic uremic syndrome]], [[Hyperlipidemia]], [[Hypovolemia]], [[Interferons]], [[Light chain disease]], [[Normocytic normochromic anemia]], [[Sickle cell disease]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Iatrogenic''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Infectious Disease''' | |||
|bgcolor="Beige"| [[Cystinosis]], [[Dioctophyma renale]], [[Schistosoma haematobium]], [[Sepsis]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Musculoskeletal/Orthopedic''' | |||
|bgcolor="Beige"| [[Action myoclonus]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Neurologic''' | |||
|bgcolor="Beige"| [[Action myoclonus ]], [[Lesch-nyhan syndrome]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Nutritional/Metabolic''' | |||
|bgcolor="Beige"| [[Acute intermittent porphyria ]], [[Adenine phosphoribosyltransferase deficiency]], [[Diabetes mellitus type 1]], [[Diabetes mellitus type 2]], [[Diabetic nephropathy]], [[Lecithin cholesterol acyltransferase deficiency]], [[Metabolic acidosis]], [[Oxalosis]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Obstetric/Gynecologic''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Oncologic''' | |||
|bgcolor="Beige"| [[Hereditary onycho-osteodysplasia]], [[Metastatic prostate cancer]], [[Multiple myeloma]], [[Prostate cancer]], [[Renal cell carcinoma]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Ophthalmologic''' | |||
|bgcolor="Beige"| [[Lecithin cholesterol acyltransferase deficiency]], [[Loken senior syndrome]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Overdose/Toxicity''' | |||
|bgcolor="Beige"| [[Cocaine]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Psychiatric''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Pulmonary''' | |||
|bgcolor="Beige"| [[Granulomatosis with polyangiitis]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Renal/Electrolyte''' | |||
|bgcolor="Beige"| [[Alport's syndrome]], [[Balkan endemic nephropathy]], [[Barakat syndrome]], [[Chronic glomerulonephritis]], [[Chronic pyelonephritis]], [[Congenital nephrotic syndrome]], [[Dense deposit disease]], [[Dent disease]], [[Denys-drash syndrome]], [[Diabetic nephropathy]], [[Dioctophyma renale]], [[Familial juvenile hyperuricemic nephropathy]], [[Fibronectin glomerulopathy]], [[Finnish congenital nephrotic syndrome]], [[Focal segmental glomerulosclerosis]], [[Glomerular hypertrophy]], [[Glomerulocystic kidney disease]], [[Glomerulonephritis]], [[Glomerulosclerosis]], [[Goodpasture’s syndrome]], [[Granulomatosis with polyangiitis]], [[Hereditary nephritides]], [[Hydronephrosis]], [[Hyperkalemia]], [[Hyperoxaluria, primary type 1]], [[Hyperoxaluria, primary type 2]], [[Hyperoxaluria, primary type 3]], [[Hyperoxaluria]], [[Hypertensive nephrosclerosis]], [[Hyperuricemic nephropathy, familial juvenile type 1]], [[Hyperuricemic nephropathy, familial juvenile type 2]], [[Idiopathic membranous nephropathy]], [[Idiopathic multicentric osteolysis]], [[Iga nephropathy]], [[Interstitial nephritis]], [[Intraglomerular hypertension]], [[Light chain disease]], [[Medullary cystic kidney disease]], [[Medullary cystic renal disease]], [[Medullary sponge kidney]], [[Membranoproliferative glomerulonephritis]], [[Membranous nephritis]], [[Nephritic syndrome]], [[Nephrolithiasis]], [[Nephrosclerosis]], [[Nephrotic syndrome]], [[Normocytic normochromic anemia]], [[Obstructive nephropathy]], [[Obstructive uropathy]], [[Oxalosis]], [[Papillorenal syndrome]], [[Polycystic kidney disease]], [[Proteinuria]], [[Pyelonephritis]], [[Reflux nephropathy]], [[Renal artery stenosis]], [[Renal cell carcinoma]], [[Renal tubular acidosis]], [[Renal vein thrombosis]], [[Systemic sclerosis]], [[Urinary tract obstruction]], [[Vesicoureteral reflux]], [[Xanthogranulomatous pyelonephritis]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Rheumatology/Immunology/Allergy''' | |||
|bgcolor="Beige"| [[Amyloidosis]], [[Goodpasture’s syndrome]], [[Gout]], [[Granulomatosis with polyangiitis]], [[Lupus nephritis]], [[Lupus]], [[Rheumatoid arthritis]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Sexual''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Trauma''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Urologic''' | |||
|bgcolor="Beige"| [[Benign prostatic hyperplasia]], [[Dent disease]], [[Familial juvenile hyperuricemic nephropathy]], [[Frasier syndrome]], [[Hemolytic uremic syndrome]] | |||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Miscellaneous''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |||
|} | |||
===Causes in Alphabetical Order=== | |||
*[[Ace inhibitors]] | |||
*[[Acetominophen]] | *[[Acetominophen]] | ||
*[[Acyclovir ]] | *[[Action myoclonus ]] | ||
*[[Acute intermittent porphyria ]] | |||
*[[Acyclovir]] | |||
*[[Adenine phosphoribosyltransferase deficiency]] | |||
*[[Allopurinol]] | *[[Allopurinol]] | ||
*[[Alport's syndrome]] | |||
*[[Alström syndrome]] | |||
*[[Aminoglycosides]] | *[[Aminoglycosides]] | ||
*[[Amphotericin | *[[Amphotericin b]] | ||
*[[Amyloidosis]] | |||
*[[Angiotensin-converting enzyme inhibitors]] | *[[Angiotensin-converting enzyme inhibitors]] | ||
*[[Anticoagulants]] | *[[Anticoagulants]] | ||
*[[Aspirin]] | *[[Aspirin]] | ||
*[[Balkan endemic nephropathy]] | |||
*[[Barakat syndrome]] | |||
*[[Bardet-biedl syndrome]] | |||
*[[Benign prostatic hyperplasia]] | |||
*[[Bevacizumab]] | *[[Bevacizumab]] | ||
*[[Bismuth]] | *[[Bismuth]] | ||
*[[Carbon tetrachloride]] | |||
*[[Carboplatin]] | *[[Carboplatin]] | ||
*[[Carmustine]] | *[[Carmustine]] | ||
*[[Cefoxitin ]] | |||
*[[Chloroquine]] | *[[Chloroquine]] | ||
*[[Chronic glomerulonephritis]] | |||
*[[Chronic pyelonephritis]] | |||
*[[Cimetidine]] | |||
*[[Cisplatin]] | *[[Cisplatin]] | ||
*[[Cocaine]] | |||
*[[Congenital nephrotic syndrome]] | |||
*[[Cyclosporine]] | *[[Cyclosporine]] | ||
*[[Cystinosis]] | |||
*[[Dense deposit disease]] | |||
*[[Dent disease]] | |||
*[[Denys-drash syndrome]] | |||
*[[Diabetes mellitus type 1]] | |||
*[[Diabetes mellitus type 2]] | |||
*[[Diabetic nephropathy]] | |||
*[[Diflunisal]] | *[[Diflunisal]] | ||
*[[Dioctophyma renale]] | |||
*[[Erythromycin]] | *[[Erythromycin]] | ||
*[[Essential hypertension]] | |||
*[[Fabry's disease]] | |||
*[[Familial juvenile hyperuricemic nephropathy]] | |||
*[[Febuxostat]] | *[[Febuxostat]] | ||
*[[ | *[[Ferumoxytol]] | ||
*[[Fibronectin glomerulopathy]] | |||
*[[Finnish congenital nephrotic syndrome]] | |||
*[[Flucytosine]] | |||
*[[Focal segmental glomerulosclerosis]] | |||
*[[Foscarnet]] | *[[Foscarnet]] | ||
*[[Frasier syndrome]] | |||
*[[Furosemide]] | *[[Furosemide]] | ||
*[[ | *[[Gadopentetate]] | ||
*[[Galloway-mowat syndrome]] | |||
*[[Gentamicin]] | *[[Gentamicin]] | ||
*[[Glomerular hypertrophy]] | |||
*[[Glomerulocystic kidney disease]] | |||
*[[Glomerulonephritis]] | |||
*[[Glomerulosclerosis]] | |||
*[[Glycogenosis type 1b]] | |||
*[[Goodpasture’s syndrome]] | |||
*[[Gout]] | |||
*[[Granulomatosis with polyangiitis]] | |||
*[[Hemolytic uremic syndrome]] | |||
*[[Hereditary nephritides]] | |||
*[[Hereditary onycho-osteodysplasia]] | |||
*[[Hydronephrosis]] | |||
*[[Hydroxychloroquine]] | *[[Hydroxychloroquine]] | ||
*[[Hyperkalemia]] | |||
*[[Hyperlipidemia]] | |||
*[[Hyperoxaluria]] | |||
*[[Hyperoxaluria, primary type 1]] | |||
*[[Hyperoxaluria, primary type 2]] | |||
*[[Hyperoxaluria, primary type 3]] | |||
*[[Hypertension]] | |||
*[[Hypertensive nephrosclerosis]] | |||
*[[Hyperuricemic nephropathy, familial juvenile type 1]] | |||
*[[Hyperuricemic nephropathy, familial juvenile type 2]] | |||
*[[Hypotension]] | |||
*[[Hypovolemia]] | |||
*[[Idiopathic membranous nephropathy]] | |||
*[[Idiopathic multicentric osteolysis]] | |||
*[[Ifosfamide]] | *[[Ifosfamide]] | ||
*[[Infliximab ]] | *[[Iga nephropathy]] | ||
*[[Infliximab]] | |||
*[[Interferons]] | |||
*[[Interstitial nephritis]] | |||
*[[Intraglomerular hypertension]] | |||
*[[Isoniazid]] | *[[Isoniazid]] | ||
*[[Jeune thoracic dystrophy syndrome]] | |||
*[[Laxatives]] | *[[Laxatives]] | ||
*[[Lead]] | |||
*[[Lecithin cholesterol acyltransferase deficiency]] | |||
*[[Lesch-nyhan syndrome]] | |||
*[[Light chain disease]] | |||
*[[Lithium]] | *[[Lithium]] | ||
*[[Loken senior syndrome]] | |||
*[[Lomustine]] | *[[Lomustine]] | ||
*[[Lowe syndrome]] | |||
*[[Lupus]] | |||
*[[Lupus nephritis]] | |||
*[[Mainzer-saldino disease]] | |||
*[[Malignant hypertension]] | |||
*[[Medullary cystic kidney disease]] | |||
*[[Medullary cystic renal disease]] | |||
*[[Medullary sponge kidney]] | |||
*[[Membranoproliferative glomerulonephritis]] | |||
*[[Membranous nephritis]] | |||
*[[Mesalamine]] | |||
*[[Metabolic acidosis]] | |||
*[[Metastatic prostate cancer]] | |||
*[[Methicillin]] | *[[Methicillin]] | ||
*[[ | *[[Mitomycin c]] | ||
*[[ | *[[Multiple myeloma]] | ||
*[[ | *[[Nephritic syndrome]] | ||
*[[ | *[[Nephrolithiasis]] | ||
*[[ | *[[Nephrosclerosis]] | ||
*[[Nephrotic syndrome]] | |||
*[[Nitrosourea]] | |||
*[[Normocytic normochromic anemia]] | |||
*[[Nsaids]] | |||
*[[Obstructive nephropathy]] | |||
*[[Obstructive uropathy]] | |||
*[[Oxalosis]] | |||
*[[Pamidronate]] | *[[Pamidronate]] | ||
*[[Papillorenal syndrome]] | |||
*[[Penicillin]] | *[[Penicillin]] | ||
*[[Pentamidine]] | *[[Pentamidine]] | ||
*[[Phenytoin ]] | *[[Phenytoin]] | ||
*[[Polycystic kidney disease]] | |||
*[[Propylthiouracil]] | *[[Propylthiouracil]] | ||
*[[Protease | *[[Prostate cancer]] | ||
*[[Protease inhibitors]] | |||
*[[Proteinuria]] | |||
*[[Pyelonephritis]] | |||
*[[Quinine]] | *[[Quinine]] | ||
*[[Radiocontrast agents]] | |||
*[[Recurrent hereditary polyserositis]] | |||
*[[Reflux nephropathy]] | |||
*[[Renal artery stenosis]] | |||
*[[Renal cell carcinoma]] | |||
*[[Renal tubular acidosis]] | |||
*[[Renal vein thrombosis]] | |||
*[[Rheumatoid arthritis]] | |||
*[[Rifampicin]] | *[[Rifampicin]] | ||
*[[Saxagliptin]] | *[[Saxagliptin]] | ||
*[[Schistosoma haematobium]] | |||
*[[Scleroderma]] | |||
*[[Sensenbrenner syndrome]] | |||
*[[Sepsis]] | |||
*[[Sickle cell disease]] | |||
*[[Sulfa-containing antibiotics]] | *[[Sulfa-containing antibiotics]] | ||
*[[Sulfonamides]] | *[[Sulfonamides]] | ||
*[[Sulindac]] | *[[Sulindac]] | ||
*[[Systemic hypertension]] | |||
*[[Systemic sclerosis]] | |||
*[[Tacrolimus]] | *[[Tacrolimus]] | ||
*[[Thiazides]] | *[[Thiazides]] | ||
*[[Thrombotic thrombocytopenic purpura]] | |||
*[[Tizanidine]] | *[[Tizanidine]] | ||
*[[Townes-brocks syndrome]] | |||
*[[Trimethoprim ]] | |||
*[[Tubulointerstitial disease]] | |||
*[[Urinary tract obstruction]] | |||
*[[Vancomycin]] | *[[Vancomycin]] | ||
*[[Vasculitis]] | |||
*[[Vesicoureteral reflux]] | |||
*[[Wegener's granulomatosis]] | |||
*[[Xanthogranulomatous pyelonephritis]] | |||
*[[ | *[[X-linked hypophosphataemia]] | ||
*[[ | *[[X-linked recessive nephrolithiasis type 1]] | ||
*[[ | |||
*[[ | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Nephrology]] |
Revision as of 19:38, 7 November 2016
Chronic renal failure Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Chronic renal failure causes On the Web |
American Roentgen Ray Society Images of Chronic renal failure causes |
Risk calculators and risk factors for Chronic renal failure causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]
Overview
Common causes of chronic renal failure include diabetic nephropathy, hypertension, and glomerulonephritis. The commonest cause of stage 5 CKD in the U.S. is diabetes and is characterized by proteinuria and bilaterally enlarged kidneys. Hypertension is the second most common cause of Stage 5 CKD in the US, and often co-exists in diabetic patients.
Causes of Chronic Kidney Disease
According to the National Kidney Foundation the 2 most important causes of CKD are diabetes and hypertension accounting for more than one third of all cases often indicating early detection strategies. Beyond diabetes and hypertension other causes like glomerulonephritis, inherited disorders, chronic infections, and urinary tract obstruction account for most of the remaining cases.[1] Following the 2013 US Renal Data System report, a detailed calculation of the most common etiologies of ESRD in the United States adjusted for age, race and gender is shown below:[2]
Common Causes
- Alport's syndrome
- Amyloidosis
- Balkan endemic nephropathy
- Benign prostatic hyperplasia
- Chronic Glomerulonephritis
- Chronic Pyelonephritis
- Cystinosis
- Diabetic nephropathy
- Glomerulosclerosis
- Goodpasture’s syndrome
- Hemolytic uremic syndrome
- Hereditary nephritides
- Hyperoxaluria
- Hypertensive nephrosclerosis
- IgA nephropathy
- Interstitial Nephritis
- Light chain disease
- Lupus nephritis
- Malignant hypertension
- Medullary cystic kidney disease
- Medullary sponge kidney
- Membranoproliferative Glomerulonephritis
- Membranous nephritis
- Metastatic prostate cancer
- Multiple Myeloma
- Nephrolithiasis
- Nephrosclerosis
- Nephrotic Syndrome
- Nephritic Syndrome
- Normocytic normochromic anemia
- Obstructive uropathy
- Oxalosis
- Papillorenal syndrome
- Polycystic kidney disease
- Proteinuria
- Prostate cancer
- Pyelonephritis
- Reflux nephropathy
- Renal artery stenosis
- Renal cell carcinoma
- Renal vein thrombosis
- Renal tubular acidosis
- Rheumatoid arthritis
- Scleroderma
- Sepsis
- Sickle cell disease
- Systemic sclerosis
- Thrombotic thrombocytopenic purpura
- Renal tubular acidosis
- Vasculitis
- Vesicoureteral reflux
- Wegener's granulomatosis
Causes by Organ System
Causes in Alphabetical Order
- Ace inhibitors
- Acetominophen
- Action myoclonus
- Acute intermittent porphyria
- Acyclovir
- Adenine phosphoribosyltransferase deficiency
- Allopurinol
- Alport's syndrome
- Alström syndrome
- Aminoglycosides
- Amphotericin b
- Amyloidosis
- Angiotensin-converting enzyme inhibitors
- Anticoagulants
- Aspirin
- Balkan endemic nephropathy
- Barakat syndrome
- Bardet-biedl syndrome
- Benign prostatic hyperplasia
- Bevacizumab
- Bismuth
- Carbon tetrachloride
- Carboplatin
- Carmustine
- Cefoxitin
- Chloroquine
- Chronic glomerulonephritis
- Chronic pyelonephritis
- Cimetidine
- Cisplatin
- Cocaine
- Congenital nephrotic syndrome
- Cyclosporine
- Cystinosis
- Dense deposit disease
- Dent disease
- Denys-drash syndrome
- Diabetes mellitus type 1
- Diabetes mellitus type 2
- Diabetic nephropathy
- Diflunisal
- Dioctophyma renale
- Erythromycin
- Essential hypertension
- Fabry's disease
- Familial juvenile hyperuricemic nephropathy
- Febuxostat
- Ferumoxytol
- Fibronectin glomerulopathy
- Finnish congenital nephrotic syndrome
- Flucytosine
- Focal segmental glomerulosclerosis
- Foscarnet
- Frasier syndrome
- Furosemide
- Gadopentetate
- Galloway-mowat syndrome
- Gentamicin
- Glomerular hypertrophy
- Glomerulocystic kidney disease
- Glomerulonephritis
- Glomerulosclerosis
- Glycogenosis type 1b
- Goodpasture’s syndrome
- Gout
- Granulomatosis with polyangiitis
- Hemolytic uremic syndrome
- Hereditary nephritides
- Hereditary onycho-osteodysplasia
- Hydronephrosis
- Hydroxychloroquine
- Hyperkalemia
- Hyperlipidemia
- Hyperoxaluria
- Hyperoxaluria, primary type 1
- Hyperoxaluria, primary type 2
- Hyperoxaluria, primary type 3
- Hypertension
- Hypertensive nephrosclerosis
- Hyperuricemic nephropathy, familial juvenile type 1
- Hyperuricemic nephropathy, familial juvenile type 2
- Hypotension
- Hypovolemia
- Idiopathic membranous nephropathy
- Idiopathic multicentric osteolysis
- Ifosfamide
- Iga nephropathy
- Infliximab
- Interferons
- Interstitial nephritis
- Intraglomerular hypertension
- Isoniazid
- Jeune thoracic dystrophy syndrome
- Laxatives
- Lead
- Lecithin cholesterol acyltransferase deficiency
- Lesch-nyhan syndrome
- Light chain disease
- Lithium
- Loken senior syndrome
- Lomustine
- Lowe syndrome
- Lupus
- Lupus nephritis
- Mainzer-saldino disease
- Malignant hypertension
- Medullary cystic kidney disease
- Medullary cystic renal disease
- Medullary sponge kidney
- Membranoproliferative glomerulonephritis
- Membranous nephritis
- Mesalamine
- Metabolic acidosis
- Metastatic prostate cancer
- Methicillin
- Mitomycin c
- Multiple myeloma
- Nephritic syndrome
- Nephrolithiasis
- Nephrosclerosis
- Nephrotic syndrome
- Nitrosourea
- Normocytic normochromic anemia
- Nsaids
- Obstructive nephropathy
- Obstructive uropathy
- Oxalosis
- Pamidronate
- Papillorenal syndrome
- Penicillin
- Pentamidine
- Phenytoin
- Polycystic kidney disease
- Propylthiouracil
- Prostate cancer
- Protease inhibitors
- Proteinuria
- Pyelonephritis
- Quinine
- Radiocontrast agents
- Recurrent hereditary polyserositis
- Reflux nephropathy
- Renal artery stenosis
- Renal cell carcinoma
- Renal tubular acidosis
- Renal vein thrombosis
- Rheumatoid arthritis
- Rifampicin
- Saxagliptin
- Schistosoma haematobium
- Scleroderma
- Sensenbrenner syndrome
- Sepsis
- Sickle cell disease
- Sulfa-containing antibiotics
- Sulfonamides
- Sulindac
- Systemic hypertension
- Systemic sclerosis
- Tacrolimus
- Thiazides
- Thrombotic thrombocytopenic purpura
- Tizanidine
- Townes-brocks syndrome
- Trimethoprim
- Tubulointerstitial disease
- Urinary tract obstruction
- Vancomycin
- Vasculitis
- Vesicoureteral reflux
- Wegener's granulomatosis
- Xanthogranulomatous pyelonephritis
- X-linked hypophosphataemia
- X-linked recessive nephrolithiasis type 1
References
- ↑ Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW; et al. (2003). "National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification". Ann Intern Med. 139 (2): 137–47. PMID 12859163 Check
|pmid=
value (help). - ↑ U.S. Renal Data System, 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2013.